End-of-day quote
Shanghai S.E.
|
5-day change
|
1st Jan Change
|
- CNY
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
5,419
|
4,890
|
4,850
|
4,917
|
11,577
|
13,634
|
-
|
Enterprise Value (EV)
1 |
3,657
|
3,610
|
3,972
|
3,836
|
10,927
|
13,634
|
13,634
|
P/E ratio
|
39.2
x
|
-11.4
x
|
216
x
|
-14.6
x
|
92.3
x
|
55.3
x
|
38.1
x
|
Yield
|
0.78%
|
1.04%
|
-
|
-
|
0.44%
|
0.16%
|
-
|
Capitalization / Revenue
|
4.9
x
|
15.8
x
|
6.63
x
|
13.3
x
|
14.6
x
|
12.7
x
|
10.3
x
|
EV / Revenue
|
4.9
x
|
15.8
x
|
6.63
x
|
13.3
x
|
14.6
x
|
12.7
x
|
10.3
x
|
EV / EBITDA
|
19.9
x
|
-14.2
x
|
21.2
x
|
-18.4
x
|
56.2
x
|
36.4
x
|
26.4
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.18
x
|
2.42
x
|
2.51
x
|
3.12
x
|
7.02
x
|
7.14
x
|
5.96
x
|
Nbr of stocks (in thousands)
|
448,200
|
448,200
|
448,200
|
448,200
|
448,200
|
448,200
|
-
|
Reference price
2 |
12.09
|
10.91
|
10.82
|
10.97
|
25.83
|
30.42
|
30.42
|
Announcement Date
|
4/24/20
|
4/23/21
|
4/26/22
|
4/26/23
|
3/11/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,107
|
309.3
|
731.1
|
368.3
|
795.2
|
1,072
|
1,328
|
EBITDA
1 |
272.9
|
-344.8
|
229.1
|
-267.3
|
206.1
|
374.3
|
516.3
|
EBIT
1 |
159.4
|
-453.2
|
26.4
|
-338.3
|
153
|
299.5
|
417.4
|
Operating Margin
|
14.41%
|
-146.53%
|
3.61%
|
-91.85%
|
19.24%
|
27.93%
|
31.43%
|
Earnings before Tax (EBT)
1 |
157.2
|
-502.6
|
16.68
|
-335
|
151.9
|
302.2
|
421.7
|
Net income
1 |
137.1
|
-431.2
|
21.87
|
-334.8
|
127
|
245.9
|
358.6
|
Net margin
|
12.39%
|
-139.42%
|
2.99%
|
-90.89%
|
15.97%
|
22.93%
|
27%
|
EPS
2 |
0.3083
|
-0.9600
|
0.0500
|
-0.7500
|
0.2800
|
0.5500
|
0.7975
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0942
|
0.1130
|
-
|
-
|
0.1140
|
0.0500
|
-
|
Announcement Date
|
4/24/20
|
4/23/21
|
4/26/22
|
4/26/23
|
3/11/24
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2024 Q1
|
---|
Net sales
1 |
157.3
|
32.14
|
189.4
|
95.47
|
177.5
|
194.4
|
257.5
|
210
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-1.287
|
-166.9
|
-168.2
|
6.689
|
35.98
|
29.86
|
58.68
|
46.11
|
Net margin
|
-0.82%
|
-519.32%
|
-88.8%
|
7.01%
|
20.26%
|
15.36%
|
22.79%
|
21.96%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/22
|
8/30/22
|
8/30/22
|
10/28/22
|
4/26/23
|
8/29/23
|
10/30/23
|
4/27/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
1,762
|
1,280
|
878
|
1,081
|
650
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
5.73%
|
-19.2%
|
1.15%
|
-19.1%
|
7.88%
|
12.9%
|
15.7%
|
ROA (Net income/ Total Assets)
|
4.06%
|
-13.4%
|
-
|
-
|
-
|
8%
|
10%
|
Assets
1 |
3,380
|
3,217
|
-
|
-
|
-
|
3,073
|
3,586
|
Book Value Per Share
2 |
5.550
|
4.510
|
4.310
|
3.510
|
3.680
|
4.260
|
5.110
|
Cash Flow per Share
2 |
0.9700
|
-0.8800
|
0.5900
|
0.2100
|
0.5500
|
0.8900
|
0.8000
|
Capex
1 |
81.5
|
42.3
|
55.3
|
67.7
|
124
|
119
|
132
|
Capex / Sales
|
7.36%
|
13.66%
|
7.56%
|
18.38%
|
15.56%
|
11.09%
|
9.94%
|
Announcement Date
|
4/24/20
|
4/23/21
|
4/26/22
|
4/26/23
|
3/11/24
|
-
|
-
|
Last Close Price
30.42
CNY Average target price
23.6
CNY Spread / Average Target -22.42% Consensus |
1st Jan change
|
Capi.
|
---|
| -.--% | 1.88B | | +17.97% | 4.62B | | +25.27% | 2.16B | | -15.44% | 1.65B | | -10.07% | 1.4B | | -3.52% | 1.24B | | -10.51% | 1.14B | | -20.74% | 1.1B | | -44.28% | 942M | | -.--% | 818M |
Movie Theaters & Movie Products
|